Search research articles
Contact Us
Filters
Showing results (131-140 of 152) with videos related to
Page
of 16
Sort By:
American Journal of Hematology
|
November 16, 2024
A prophylactic tyrosine kinase inhibitor strategy based on measurable residual disease pre-transplantation for Ph<sup>+</sup> acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation: A prospective multicenter cohort study
Hui Liu, Hui Xu, Peiru Chi, et al.
Journal of Hepatology
|
October 29, 2022
Prognostic and therapeutic significance of microbial cell-free DNA in plasma of people with acute decompensation of cirrhosis
Beiling Li, Changze Hong, Zhiping Fan, et al.
Biomarker Research
|
August 20, 2025
Salvage therapy containing sorafenib and donor lymphocyte infusion is associated with improved outcomes for FLT3 wild-type acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation
Zhonghui Jiang, Ya Zhou, Yuxin Bai, et al.
BMJ Open
|
December 30, 2023
Changing epidemiology, microbiology and mortality of bloodstream infections in patients with haematological malignancies before and during SARS-CoV-2 pandemic: a retrospective cohort study
Linjing Cai, Huan Chen, Yongqiang Wei, et al.
Transplantation
|
April 21, 2018
Therapeutic Outcomes of Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Severe Aplastic Anemia: A Multicenter Study
Yonghua Li, Fengqi Duan, Haowen Xiao, et al.
The Lancet. Oncology
|
August 14, 2020
Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial
Li Xuan, Yu Wang, Fen Huang, et al.
Blood Cancer Journal
|
February 19, 2025
Effect of pre-transplant cytoreductive therapy on the outcomes of patients with MDS or secondary AML evolving from MDS undergoing allo-HSCT: a secondary analysis of an RCT
Rongtao Xue, Min Dai, Erlie Jiang, et al.
The Lancet. Haematology
|
February 7, 2025
Haploidentical peripheral blood stem cells combined with bone marrow or unrelated cord blood as grafts for haematological malignancies: an open-label, multicentre, randomised, phase 3 trial
Sijian Yu, Fen Huang, Na Xu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 19, 2023
Busulfan Plus Fludarabine Compared With Busulfan Plus Cyclophosphamide for AML Undergoing HLA-Haploidentical Hematopoietic Cell Transplantation: A Multicenter Randomized Phase III Trial
Yiwen Ling, Li Xuan, Na Xu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 13, 2024
Erratum: Busulfan Plus Fludarabine Compared With Busulfan Plus Cyclophosphamide for AML Undergoing HLA-Haploidentical Hematopoietic Cell Transplantation: A Multicenter Randomized Phase III Trial
Yiwen Ling, Li Xuan, Na Xu, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 152) with videos related to
Sort By:
Page
of 16
American Journal of Hematology
|
November 16, 2024
A prophylactic tyrosine kinase inhibitor strategy based on measurable residual disease pre-transplantation for Ph<sup>+</sup> acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation: A prospective multicenter cohort study
Hui Liu, Hui Xu, Peiru Chi, et al.
Journal of Hepatology
|
October 29, 2022
Prognostic and therapeutic significance of microbial cell-free DNA in plasma of people with acute decompensation of cirrhosis
Beiling Li, Changze Hong, Zhiping Fan, et al.
Biomarker Research
|
August 20, 2025
Salvage therapy containing sorafenib and donor lymphocyte infusion is associated with improved outcomes for FLT3 wild-type acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation
Zhonghui Jiang, Ya Zhou, Yuxin Bai, et al.
BMJ Open
|
December 30, 2023
Changing epidemiology, microbiology and mortality of bloodstream infections in patients with haematological malignancies before and during SARS-CoV-2 pandemic: a retrospective cohort study
Linjing Cai, Huan Chen, Yongqiang Wei, et al.
Transplantation
|
April 21, 2018
Therapeutic Outcomes of Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Severe Aplastic Anemia: A Multicenter Study
Yonghua Li, Fengqi Duan, Haowen Xiao, et al.
The Lancet. Oncology
|
August 14, 2020
Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial
Li Xuan, Yu Wang, Fen Huang, et al.
Blood Cancer Journal
|
February 19, 2025
Effect of pre-transplant cytoreductive therapy on the outcomes of patients with MDS or secondary AML evolving from MDS undergoing allo-HSCT: a secondary analysis of an RCT
Rongtao Xue, Min Dai, Erlie Jiang, et al.
The Lancet. Haematology
|
February 7, 2025
Haploidentical peripheral blood stem cells combined with bone marrow or unrelated cord blood as grafts for haematological malignancies: an open-label, multicentre, randomised, phase 3 trial
Sijian Yu, Fen Huang, Na Xu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 19, 2023
Busulfan Plus Fludarabine Compared With Busulfan Plus Cyclophosphamide for AML Undergoing HLA-Haploidentical Hematopoietic Cell Transplantation: A Multicenter Randomized Phase III Trial
Yiwen Ling, Li Xuan, Na Xu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 13, 2024
Erratum: Busulfan Plus Fludarabine Compared With Busulfan Plus Cyclophosphamide for AML Undergoing HLA-Haploidentical Hematopoietic Cell Transplantation: A Multicenter Randomized Phase III Trial
Yiwen Ling, Li Xuan, Na Xu, et al.
Page
of 16